Implementation strategies are now needed to get polypills into the hands of more patients, particularly in poorer countries.

Risk factors in adults with cardiovascular disease are worsening over time despite advances in secondary prevention, study shows. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com ...

Secondary prevention of heart disease and cardiovascular disease principally involves mitigating risk among individuals considered to be at high risk for serious adverse events that include stroke ...

In 2007–2008, antiplatelet medications were prescribed at only 46.9% of visits for patients with ischemic vascular disease. ... Aspirin in the Secondary Prevention of Cardiovascular Disease.

The US Preventive Services Task Force recommends against adults 60 and older starting on low-dose aspirin for the primary prevention of cardiovascular disease, and for people ages 40 to 59 who ...

Despite the abundant evidence base for the secondary prevention of coronary artery disease, 1 many of these therapies are underused in clinical practice. 1 – 4 These gaps between evidence and clinical ...

Long-term Secondary Prevention Program May Help Reduce Cardiovascular Risks After Heart Attack. ScienceDaily . Retrieved May 31, 2025 from www.sciencedaily.com / releases / 2008 / 11 ...

Atherothrombosis underlies numerous manifestations of cardiovascular disease, including coronary artery disease (CAD) and cerebrovascular disease (CVD). Treatment of patients with concomitant CAD ...

Low-dose aspirin is among the most widely used agents for the prevention of cardiovascular disease. 4-8 Its efficacy has been established in secondary prevention trials, in which the benefits ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to ...

Cardiovascular disease remains a leading cause of death worldwide, and managing it effectively requires more than just ...